Your browser doesn't support javascript.
loading
Cyclophilin A Inhibitor Debio-025 Targets Crk, Reduces Metastasis, and Induces Tumor Immunogenicity in Breast Cancer.
Davra, Viralkumar; Saleh, Tamjeed; Geng, Ke; Kimani, Stanley; Mehta, Dhriti; Kasikara, Canan; Smith, Brendan; Colangelo, Nicholas W; Ciccarelli, Bryan; Li, Hong; Azzam, Edouard I; Kalodimos, Charalampos G; Birge, Raymond B; Kumar, Sushil.
Afiliação
  • Davra V; Department of Microbiology, Biochemistry and Molecular Genetics, Center for Cell Signaling, Rutgers- New Jersey Medical School, Newark, New Jersey.
  • Saleh T; Department of Structural Biology, St Jude Children's Research Hospital, Memphis, Tennessee.
  • Geng K; Department of Microbiology, Biochemistry and Molecular Genetics, Center for Cell Signaling, Rutgers- New Jersey Medical School, Newark, New Jersey.
  • Kimani S; Department of Microbiology, Biochemistry and Molecular Genetics, Center for Cell Signaling, Rutgers- New Jersey Medical School, Newark, New Jersey.
  • Mehta D; Department of Microbiology, Biochemistry and Molecular Genetics, Center for Cell Signaling, Rutgers- New Jersey Medical School, Newark, New Jersey.
  • Kasikara C; Department of Microbiology, Biochemistry and Molecular Genetics, Center for Cell Signaling, Rutgers- New Jersey Medical School, Newark, New Jersey.
  • Smith B; Department of Microbiology, Biochemistry and Molecular Genetics, Center for Cell Signaling, Rutgers- New Jersey Medical School, Newark, New Jersey.
  • Colangelo NW; Department of Radiology, Center for Cell Signaling, Rutgers- New Jersey Medical School, Newark, New Jersey.
  • Ciccarelli B; Department of Microbiology, Biochemistry and Molecular Genetics, Center for Cell Signaling, Rutgers- New Jersey Medical School, Newark, New Jersey.
  • Li H; Center for Advanced Proteomics, Rutgers University, Newark, New Jersey.
  • Azzam EI; Department of Radiology, Center for Cell Signaling, Rutgers- New Jersey Medical School, Newark, New Jersey.
  • Kalodimos CG; Department of Structural Biology, St Jude Children's Research Hospital, Memphis, Tennessee.
  • Birge RB; Department of Microbiology, Biochemistry and Molecular Genetics, Center for Cell Signaling, Rutgers- New Jersey Medical School, Newark, New Jersey. sushil_kumar@dfci.harvard.edu birgera@njms.rutgers.edu.
  • Kumar S; Department of Microbiology, Biochemistry and Molecular Genetics, Center for Cell Signaling, Rutgers- New Jersey Medical School, Newark, New Jersey. sushil_kumar@dfci.harvard.edu birgera@njms.rutgers.edu.
Mol Cancer Res ; 18(8): 1189-1201, 2020 08.
Article em En | MEDLINE | ID: mdl-32321766
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias da Mama / Ciclosporina / Peptidilprolil Isomerase / Proteínas Proto-Oncogênicas c-crk / Inibidores de Checkpoint Imunológico Limite: Animals / Female / Humans Idioma: En Revista: Mol Cancer Res Assunto da revista: BIOLOGIA MOLECULAR / NEOPLASIAS Ano de publicação: 2020 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias da Mama / Ciclosporina / Peptidilprolil Isomerase / Proteínas Proto-Oncogênicas c-crk / Inibidores de Checkpoint Imunológico Limite: Animals / Female / Humans Idioma: En Revista: Mol Cancer Res Assunto da revista: BIOLOGIA MOLECULAR / NEOPLASIAS Ano de publicação: 2020 Tipo de documento: Article